Medical network - April 6, bidding bargain a busy drop drop drop! But some medicines upstream, rising prices, a than a high! 

 

▍ shortage in drug screening for many times, still can't buy 

 

Released recently, the drug centralized bid procurement affairs management of Shanghai procurement notice of the shortage of clinical drug screening. Procurement including "vitamin K1 injection" and "magnesium sulfate injection", four products, shortage of clinical medicine, is quite urgent. 

 

In fact, this is not the first time in Shanghai to release such notification. Enter since 2017, the shortage of clinical medicine, medicine for Shanghai has released a total of 4 times. And more details show that a shortage of these drugs directly net purchase did not go well. 

 

Because some products, continuous appear in the notification. Such as "vitamin K1 injection", on March 21, Shanghai will hang net purchase, in the notice on April 1, still said the drug shortage; Magnesium sulfate injection "and", March 21, on February 10, shortages, shortage, to April 1, or in short supply. 

 

Procure the specifications of the same, but different manufacturers. According to the normal logic speculate that is likely to be this: no drug firms are willing to supply, only change the manufacturers try again next month. 

 

▍ purchasing price again and again, crisis obstinacy 

 

Shortage of clinical medicine, urgent rescue medications (rob) outages, bidding, the blue parker had reported that liaoning had 57 product of out of stock, therefore liaoning also sent there. Main reason for the previous have been discussed, the main is the price. This in Shanghai for four times in the notice, also has a full display. 

 

Such as vitamin K1 injection, march Shanghai purchasing give reference price is 7.35 yuan /, in April, the same specifications, the price rose to 9.9 yuan/branch; "Magnesium sulfate injection", the price is 9.8 yuan / 2 month, up to 15 yuan/April. 

 

In comparison, Shanghai given price, at least is much taller than in liaoning. "Vitamin K1 injection" liaoning hang WangJia is 1.2 yuan /, sure enough, because should really be discussing price, liaoning notice 57 shortage of drugs, physical there is this. Now, officials have to raise prices, means that the hospital will buy these products with higher price than the original. 

 

▍ cheap medicine disappear acceleration, who is going to stop? 

 

Turn the situation, in the case of a shortage of medicine is a seller's market now. No production loss to drug companies, such as the out of stock in the former period of mitomycin for injection, the approval document number of holding three drug firms, all have no production. However, clinical is to be used, lack of substitutes or alternatives to expensive. 

 

In adherence to the lower price of centralized purchasing, appear this kind of circumstance, presumably also is to let the official in a quandary. Repeated price whether can get purchasing to the shortage of drugs? It's hard to say. Cannot use the administrative commands or code of ethics to cooperate under the premise of enterprise, the purchaser is a test. 

 

Perhaps, as has the industry suggests, for shortage of medicine in terms of distribution, tax also offer certain preferential policy and subsidies. Or, simply make a production contract for reimbursement. Otherwise, more and more cheap medicine will disappear. 

 

Attachment: Shanghai listing shortage of medicine